FORTITUDE Trial interim results

The company Avidity shared a press release to announce initial AOC 1020 data from the Phase 1/2 FORTITUDE™ trial in adults living with FSHD.

To learn more about these findings, you can watch the recording of the online webinar in partnership with the FSHD Society 6 20 24 FSHDUniversity Avidity Fortitude Update (youtube.com) and see the presentation slides here: FINAL_FSHD-University-FORTITUDE-Interim-Results.pdf (fshdsociety.org).

Find more information: Avidity shares interim data from its FORTITUDE trial | FSHD Society